Bvf Partners L P/Il

Insider Reports History

Entity
Company
Location
44 Montgomery St., 40 Th Floor, San Francisco, CA
Signature
BVF Partners L.P., By: BVF Inc., its general partner, By: /s/ Mark N. Lampert, President
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bvf Partners L P/Il:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MoonLake Immunotherapeutics Director, 10%+ Owner Class A Ordinary Shares, $0.0001 par value 1.29M $64.4M $50.00 Oct 4, 2024 Direct
Kymera Therapeutics, Inc. Director, Other* Common Stock, $0.0001 par value 295K $13.7M $46.41 Aug 20, 2024 Direct
Verastem, Inc. 10%+ Owner Common Stock 994K $10.9M $10.95 Jan 25, 2022 Direct
Merus N.V. 10%+ Owner Common Shares, (euro)0.09 nominal value per share 233K $6.47M $27.79 Oct 8, 2021 Direct
Kymera Therapeutics, Inc. Director, Other* Pre-Funded Warrants to Purchase Common Stock 157K $6.39M $40.75 Aug 20, 2024 Direct
ESSA Pharma Inc. 10%+ Owner Common Stock 357K $3.58M $10.01 Jul 11, 2022 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Pre-funded Warrants to Purchase Common Stock 839K $3.06M $3.65 Oct 29, 2024 Direct
Repare Therapeutics Inc. 10%+ Owner Common Shares, no par value 549K $2.96M $5.38 Nov 16, 2023 Direct
Olema Pharmaceuticals, Inc. Director, Other* Pre-Funded Warrant 314K $2.85M $9.08 Dec 4, 2024 Direct
Olema Pharmaceuticals, Inc. Director, Other* Common stock, $0.0001 par value 371K $2.6M $7.02 Dec 4, 2024 Direct
Third Harmonic Bio, Inc. Other* Common Stock 177K $2.53M $14.30 Oct 29, 2024 Direct
Allakos Inc. 10%+ Owner Common Stock, $0.001 par value 855K $2.14M $2.50 Jan 16, 2024 Direct
XOMA Corp Director, Other*, 10%+ Owner Common Stock, $0.0075 par value per share 75.3K $1.65M $21.98 May 17, 2023 Direct
4D Molecular Therapeutics, Inc. Other* Common Stock, $0.0001 par value 87.9K $1.44M $16.33 Nov 8, 2024 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Common Stock, $0.001 par value 220K $988K $4.48 Oct 29, 2024 Direct
Cullinan Oncology, Inc. 10%+ Owner Common Stock 64.2K $799K $12.46 Jan 19, 2023 Direct
Olema Pharmaceuticals, Inc. Director, Other* Common stock, $0.0001 par value 99.6K $699K $7.02 Dec 4, 2024 Indirect
PIERIS PHARMACEUTICALS, INC. Other* Common Stock, $0.001 par value 39K $619K $15.88 Dec 13, 2024 Direct
XOMA Corp Director, Other*, 10%+ Owner Common Stock, $0.0075 par value per share 11.8K $259K $21.98 May 17, 2023 Indirect
Rain Oncology Inc. Director, Other* Common Stock, $0.001 par value 0 $0 $1.21 Jan 25, 2024 Direct
MoonLake Immunotherapeutics Director, 10%+ Owner Class A Ordinary Shares, $0.0001 par value 1.42M Jun 6, 2024 Direct
Structure Therapeutics Inc. 10%+ Owner Convertible Non-Voting Ordinary Shares 463K May 10, 2023 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Warrants to Purchase Common Stock 252K Oct 29, 2024 Direct
4D Molecular Therapeutics, Inc. Other* Pre-Funded Warrant 240K Nov 8, 2024 Direct
XOMA Corp Director, Other*, 10%+ Owner 8.625% Series A Cumulative Perpetual Preferred Stock 200K May 17, 2023 Indirect
enGene Holdings Inc. 10%+ Owner Class A Common Shares 104K Oct 31, 2023 Direct
Cullinan Oncology, Inc. 10%+ Owner Series A Convertible Preferred Stock 30K Jan 19, 2023 Direct
Olema Pharmaceuticals, Inc. Director, Other* Stock Option (Right to buy) 21.5K Dec 4, 2024 Indirect
Kymera Therapeutics, Inc. Director, Other* Stock Option (Right to Buy) 12K Aug 20, 2024 Indirect
MoonLake Immunotherapeutics Director, 10%+ Owner Option to Buy 11.3K Oct 4, 2024 Indirect
XOMA Corp Director, Other*, 10%+ Owner Non-Qualified Stock Option (right to buy) 11K May 17, 2023 Indirect
Eledon Pharmaceuticals, Inc. 10%+ Owner Series X1 Convertible Preferred 7.64K Oct 29, 2024 Direct
XOMA Corp Director, Other*, 10%+ Owner Series X Convertible Preferred Stock 772 May 17, 2023 Indirect
XOMA Corp Director, Other*, 10%+ Owner Series X Convertible Preferred Stock 412 May 17, 2023 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Series X Convertible Preferred 346 Oct 29, 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series B Convertible Preferred Stock, $0.001 par value 284 Dec 13, 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series C Convertible Preferred Stock, $0.001 par value 265 Dec 13, 2024 Direct
Eledon Pharmaceuticals, Inc. 10%+ Owner Warrants to Purchase Series X1 Convertible Preferred Stock 189 Oct 29, 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series D Convertible Preferred Stock, $0.001 par value 163 Dec 13, 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series E Convertible Preferred Stock, $0.001 par value 161 Dec 13, 2024 Direct
PIERIS PHARMACEUTICALS, INC. Other* Series A Convertible Preferred Stock, $0.001 par value 85 Dec 13, 2024 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Common Stock, par value $0.001 0 $9.10 Jun 26, 2023 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Common Stock, par value $0.001 0 $9.10 Jun 26, 2023 Indirect
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Series X1 Convertible Preferred Stock 0 Jun 26, 2023 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Series X Convertible Preferred Stock 0 Jun 26, 2023 Direct
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Series X Convertible Preferred Stock 0 Jun 26, 2023 Indirect
CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Stock Option (Right to Buy) 0 Jun 26, 2023 Indirect
POINT Biopharma Global Inc. Former 10% Owner Common Stock, $0.0001 par value 0 $12.45 Dec 18, 2023 Direct
Rain Oncology Inc. Director, Other* Non-Voting Common Stock, $0.001 par value 0 Jan 25, 2024 Direct
Rain Oncology Inc. Director, Other* Stock Option (Right to Buy) 0 Jan 26, 2024 Indirect
Structure Therapeutics Inc. 10%+ Owner Ordinary Shares, $0.0001 par value per share 0 May 10, 2023 Direct

Insider Reports Filed by Bvf Partners L P/Il

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PVLA PALVELLA THERAPEUTICS, INC. Dec 13, 2024 3 $0 4 Dec 17, 2024 Other*
OLMA Olema Pharmaceuticals, Inc. Dec 4, 2024 9 $22.4M 4 Dec 4, 2024 Director, Other*
FDMT 4D Molecular Therapeutics, Inc. Nov 8, 2024 6 $0 4 Nov 13, 2024 Other*
THRD Third Harmonic Bio, Inc. Oct 29, 2024 3 -$14.3M 4 Oct 31, 2024 Other*
ELDN Eledon Pharmaceuticals, Inc. Oct 29, 2024 3 $17.3M 4 Oct 31, 2024 10%+ Owner
MLTX MoonLake Immunotherapeutics Oct 4, 2024 3 -$100M 4 Oct 8, 2024 Director, 10%+ Owner
KYMR Kymera Therapeutics, Inc. Aug 20, 2024 2 $14.6M 4 Aug 22, 2024 Director, Other*
FDMT 4D Molecular Therapeutics, Inc. Jul 22, 2024 0 $0 3 Aug 1, 2024 10%+ Owner
KYMR Kymera Therapeutics, Inc. Jun 18, 2024 1 $0 4 Jun 28, 2024 Director, Other*
OLMA Olema Pharmaceuticals, Inc. Jun 14, 2024 1 $0 4 Jun 18, 2024 Director, 10%+ Owner
MLTX MoonLake Immunotherapeutics Jun 6, 2024 1 $0 4 Jun 10, 2024 Director, 10%+ Owner
ELDN Eledon Pharmaceuticals, Inc. May 9, 2024 6 $0 4 May 13, 2024 10%+ Owner
RAIN Rain Oncology Inc. Jan 25, 2024 8 $0 4 Jan 29, 2024 Director, Other*
ALLK Allakos Inc. Jan 16, 2024 0 $0 3 Jan 26, 2024 10%+ Owner
KYMR Kymera Therapeutics, Inc. Jan 5, 2024 3 $24.7M 4 Jan 9, 2024 Director, Other*
PNT POINT Biopharma Global Inc. Dec 18, 2023 3 -$214M 4 Dec 20, 2023 Former 10% Owner
RPTX Repare Therapeutics Inc. Nov 15, 2023 6 $6.25M 4 Nov 17, 2023 10%+ Owner
KYMR Kymera Therapeutics, Inc. Nov 2, 2023 6 $5.3M 4 Nov 6, 2023 Director, Other*
PNT POINT Biopharma Global Inc. Nov 2, 2023 0 $0 3 Nov 6, 2023 10%+ Owner
RPTX Repare Therapeutics Inc. Nov 2, 2023 3 $2.82M 4 Nov 3, 2023 10%+ Owner
ENGN enGene Holdings Inc. Oct 31, 2023 0 $0 3 Nov 13, 2023 10%+ Owner
OLMA Olema Pharmaceuticals, Inc. Sep 12, 2023 4 $14.8M 4 Sep 14, 2023 Director, 10%+ Owner
CTIC CTI BIOPHARMA CORP Jun 26, 2023 18 -$80.6M 4 Jun 28, 2023 Director, Other*, 10%+ Owner
OLMA Olema Pharmaceuticals, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director, 10%+ Owner
KYMR Kymera Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director, Other*
MLTX MoonLake Immunotherapeutics Jun 8, 2023 1 $0 4 Jun 12, 2023 Director, 10%+ Owner
XOMA XOMA Corp May 17, 2023 1 $0 4 May 19, 2023 Director, Other*, 10%+ Owner
PIRS PIERIS PHARMACEUTICALS, INC. May 11, 2023 0 $0 3 May 22, 2023 10%+ Owner
GPCR Structure Therapeutics Inc. May 10, 2023 6 $0 4 May 12, 2023 10%+ Owner
ELDN Eledon Pharmaceuticals, Inc. May 5, 2023 9 $0 4 May 9, 2023 10%+ Owner
CTIC CTI BIOPHARMA CORP Apr 5, 2023 1 $0 4 Apr 7, 2023 Director, Other*, 10%+ Owner
GPCR Structure Therapeutics Inc. Feb 3, 2023 0 $0 3 Feb 13, 2023 10%+ Owner
CGEM Cullinan Oncology, Inc. Jan 19, 2023 6 $0 4 Jan 19, 2023 10%+ Owner
KYMR Kymera Therapeutics, Inc. Jan 11, 2023 4 $1.25M 4 Jan 13, 2023 Director, Other*
XOMA XOMA Corp Jan 5, 2023 4 $421K 4 Jan 9, 2023 Director, Other*, 10%+ Owner
THRD Third Harmonic Bio, Inc. Dec 20, 2022 3 $879K 4 Dec 22, 2022 10%+ Owner
THRD Third Harmonic Bio, Inc. Dec 19, 2022 0 $0 3 Dec 22, 2022 10%+ Owner
RAIN Rain Therapeutics Inc. Nov 8, 2022 3 $9.97M 4 Nov 10, 2022 Director, Other*, 10%+ Owner
XOMA XOMA Corp Sep 23, 2022 6 $409K 4 Sep 27, 2022 Director, Other*, 10%+ Owner
XOMA XOMA Corp Sep 14, 2022 4 $991K 4 Sep 16, 2022 Director, Other*, 10%+ Owner
KYMR Kymera Therapeutics, Inc. Aug 22, 2022 3 $14.2M 4 Aug 23, 2022 Director, Other*
CTIC CTI BIOPHARMA CORP Aug 9, 2022 12 -$52M 4 Aug 11, 2022 Director, Other*, 10%+ Owner
EPIX ESSA Pharma Inc. Jul 11, 2022 0 $0 3 Jul 21, 2022 10%+ Owner
FDMT 4D Molecular Therapeutics, Inc. Jun 16, 2022 0 $0 3 Jun 27, 2022 10%+ Owner
KYMR Kymera Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director, Other*
RPTX Repare Therapeutics Inc. Jun 13, 2022 3 $1.9M 4 Jun 15, 2022 10%+ Owner
OLMA Olema Pharmaceuticals, Inc. Jun 10, 2022 2 $807K 4 Jun 14, 2022 Director, 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 2, 2022 9 $21.9M 4 Jun 6, 2022 10%+ Owner
CGEM Cullinan Oncology, Inc. Jun 1, 2022 3 $8.26M 4 Jun 3, 2022 10%+ Owner
KYMR Kymera Therapeutics, Inc. May 26, 2022 6 $4.15M 4 May 31, 2022 Director, Other*
KYMR Kymera Therapeutics, Inc. May 20, 2022 3 $141K 4 May 24, 2022 Director, Other*
XOMA XOMA Corp May 18, 2022 1 $0 4 May 20, 2022 Director, Other*, 10%+ Owner
RPTX Repare Therapeutics Inc. May 18, 2022 3 $3.57M 4 May 20, 2022 10%+ Owner
CGEM Cullinan Oncology, Inc. May 12, 2022 5 $10.1M 4 May 16, 2022 10%+ Owner
KYMR Kymera Therapeutics, Inc. May 5, 2022 6 $4.87M 4 May 9, 2022 Director, Other*
MLTX MoonLake Immunotherapeutics Apr 5, 2022 0 $0 3 Apr 15, 2022 Director, 10%+ Owner
CGEM Cullinan Oncology, Inc. Apr 1, 2022 2 $2.97M 4 Apr 5, 2022 10%+ Owner
CTIC CTI BIOPHARMA CORP Mar 9, 2022 1 $0 4 Mar 11, 2022 Director, Other*, 10%+ Owner
KYMR Kymera Therapeutics, Inc. Jan 27, 2022 4 $5.08M 4 Jan 31, 2022 Director, Other*
VSTM Verastem, Inc. Jan 25, 2022 0 $0 3 Feb 7, 2022 10%+ Owner
KYMR Kymera Therapeutics, Inc. Jan 24, 2022 2 $10.3M 4 Jan 26, 2022 Director, Other*
ELDN Eledon Pharmaceuticals, Inc. Jan 20, 2022 0 $0 3 Jan 31, 2022 10%+ Owner
RPTX Repare Therapeutics Inc. Jan 19, 2022 3 $14.1M 4 Jan 21, 2022 10%+ Owner
RAIN Rain Therapeutics Inc. Jan 6, 2022 4 $6.69M 4 Jan 10, 2022 Director, Other*, 10%+ Owner
CGEM Cullinan Oncology, Inc. Dec 31, 2021 0 $0 3 Jan 10, 2022 10%+ Owner
OLMA Olema Pharmaceuticals, Inc. Nov 30, 2021 3 $6.95M 4 Dec 2, 2021 Director, 10%+ Owner
RPTX Repare Therapeutics Inc. Oct 28, 2021 0 $0 3 Nov 8, 2021 10%+ Owner
MRUS Merus N.V. Oct 7, 2021 6 -$31.2M 4 Oct 8, 2021 10%+ Owner
RAIN Rain Therapeutics Inc. Sep 21, 2021 3 $154K 4 Sep 23, 2021 Director, Other*, 10%+ Owner
RAIN Rain Therapeutics Inc. Sep 13, 2021 3 $6.47M 4 Sep 15, 2021 Director, Other*, 10%+ Owner
MRUS Merus N.V. Jul 2, 2021 3 -$45.4M 4 Jul 7, 2021 10%+ Owner
RAIN Rain Therapeutics Inc. Jul 1, 2021 6 $9.08M 4 Jul 6, 2021 Director, Other*, 10%+ Owner
KYMR Kymera Therapeutics, Inc. Jul 1, 2021 3 $25.6M 4 Jul 6, 2021 Director, Other*
KYMR Kymera Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director, Other*
RAIN Rain Therapeutics Inc. May 21, 2021 6 $1.97M 4 May 25, 2021 Director, Other*, 10%+ Owner
XOMA XOMA Corp May 19, 2021 1 $0 4 May 21, 2021 Director, Other*, 10%+ Owner
RAIN Rain Therapeutics Inc. May 18, 2021 6 $3.46M 4 May 20, 2021 Director, Other*
RAIN Rain Therapeutics Inc. May 13, 2021 3 $827K 4 May 17, 2021 Director, Other*
RAIN Rain Therapeutics Inc. Apr 23, 2021 9 $19.1M 4/A May 17, 2021 Director, Other*
OLMA Olema Pharmaceuticals, Inc. Mar 31, 2021 1 $0 4 May 26, 2021 Director, 10%+ Owner